Mycenax Biotech Inc. (TPEX:4726)
Taiwan · Delayed Price · Currency is TWD 31.60
-0.40 (-1.25%)
Dec 31, 2025, 2:31 PM CST
Mycenax Biotech Market Cap
Mycenax Biotech has a market cap or net worth of 6.55 billion as of December 31, 2025. Its market cap has decreased by -27.48% in one year.
Market Cap
6.55B
Enterprise Value
7.45B
Revenue
649.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.60
Market Cap Chart
Since October 31, 2008, Mycenax Biotech's market cap has increased from 584.10M to 6.55B, an increase of 1,020.95%. That is a compound annual growth rate of 15.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 6.55B | -26.98% |
| Dec 31, 2024 | 8.97B | 22.00% |
| Dec 29, 2023 | 7.35B | -4.53% |
| Dec 30, 2022 | 7.70B | 32.48% |
| Dec 30, 2021 | 5.81B | 40.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 240.39B |
| PharmaEssentia | 173.83B |
| Lotus Pharmaceutical | 74.42B |
| Heron Neutron Medical | 70.65B |
| Bora Pharmaceuticals Co., LTD. | 60.52B |
| Lin BioScience | 32.84B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 31.06B |